IL6 and endometriosis: Therefore, the synergistic action of ARID1A loss and PI3K/AKT/mTOR pathway upregulation in the malignant progression of endometriosis can be partially explained by their cooperation in activating IL-6 and thus in promoting a pro-tumorigenic inflammatory cytokine signaling (Figure 2).